Cochrane · systematic review · CD007720
Corticosteroids for pneumonia
Stern, A, Skalsky, K, Avni, T, et al. · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library
Acute Respiratory InfectionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 4 · 57.1%High 3 · 42.9%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Corticosteroids compared to control for pneumonia
Population: people with community‐acquired pneumonia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Mortality ‐ adults Corticosteroids vs control | RR 0.66 [0.47, 0.92] | 11 studies · 1863 participants | Moderate Downgraded: risk of bias |
Mortality ‐ adults ‐ severe CAP Corticosteroids vs control | RR 0.58 [0.4, 0.84] | 9 studies · 995 participants | Moderate Downgraded: risk of bias |
Mortality ‐ adults ‐ non‐severe CAP Corticosteroids vs control | RR 0.95 [0.45, 2] | 4 studies · 868 participants | Moderate Downgraded: imprecision |
Early clinical failure ‐ adults Corticosteroids vs control | RR 0.4 [0.23, 0.7] | 6 studies · 1324 participants | Moderate Downgraded: risk of bias, inconsistency |
Early clinical failure ‐ adults ‐ severe CAP Corticosteroids vs control | RR 0.32 [0.15, 0.7] | 5 studies · 419 participants | High |
Early clinical failure ‐ adults ‐ non‐severe CAP Corticosteroids vs control | RR 0.68 [0.56, 0.83] | 2 studies · 905 participants | High |
Early clinical failure ‐ children Corticosteroids vs control | RR 0.41 [0.24, 0.7] | 2 studies · 88 participants | High |